FDA Authorizes First At-Home Sample Collection Test for COVID-19
WASHINGTON – The Food and Drug Administration Tuesday approved the first diagnostic test for the coronavirus that allows people to collect their sample at home — a development that could greatly expand testing options in states fighting to corral the outbreak.
The COVID-19 RT-PCR from LabCorp will initially only be available to health care workers and first responders under a doctor’s orders.
The sample, collected via swab, will still have to be shipped for processing back to LabCorp, which operates diagnostic labs throughout the U.S.
Before gaining access to the home test, people are screened using an online questionnaire.
If authorized by a physician, LabCorp will ship a testing kit to their home.
The kit includes cotton swabs, a collection tube, an insulated pouch and box to ship the specimen back to LabCorp. To take a sample, a cotton swab is swirled in each nostril. The test results are posted online to a secure company website.
The company said it will make the test kit available in the coming weeks. Each will cost $119. The kits will not be available in Maryland, New Jersey, New York and Rhode Island. Those states have laws prohibiting testing with at-home kits.
FDA Commissioner Stephan Hawn said in a statement the agency authorized the self-swab test based on data showing it is “as safe and accurate as sample collection at a doctor’s office, hospital or other testing site.”
“Throughout this pandemic we have been facilitating test development to ensure patients access to accurate diagnostics, which includes supporting the development of reliable and accurate at-home sample collection options,” he said.
“The FDA’s around-the-clock work since this outbreak began has resulted in the authorization of more than 50 diagnostic tests and engagement with over 350 test developers,” he continued.
The FDA said it will continue to work with test developers to determine whether or not Q-tip-style cotton swabs can be used safely and effectively with other tests.
In The News
At the onset of the COVID-19 pandemic, it became clear that the nation’s manufacturing capabilities were ill-prepared to respond to the urgent needs of the medical community. As the pandemic’s scope progressed, so did China’s chokehold on supplying countries with personal protective equipment and other front-line... Read More
The Supreme Court on Thursday dismissed a challenge to the Affordable Care Act, preserving insurance coverage for millions of Americans. By a 7-2 vote, the justices left the entire law intact and ruled that Texas and other Republican-led states (as well as two individual plaintiffs) have... Read More
MINNETONKA, Minn. — UnitedHealthcare announced it would delay plans to implement policy changes that would retroactively deny emergency medical care coverage to its customers if the company determines the reason for the care does not qualify as an emergency. Initially set to take effect on July... Read More
Researchers from the Guangzhou Women and Children's Medical Center in China published a study this week in the medical journal Development, offering new insight into preventing infertility in men. Currently, at least 30 million men worldwide are infertile, and one in seven couples are considered clinically... Read More
The House Committee on Financial Services met this past week to discuss how increasing Section 8 housing vouchers could reduce housing instability, overcrowding, and better prepare the nation for the next health or economic crisis. “Providing a voucher to all eligible households would lift 9.3 million... Read More
The COVID-19 pandemic has disrupted routine health services making it difficult to deliver high-quality care to pregnant women and children living with HIV. But it has also pushed global leaders to try and reinvigorate global commitments to eliminate pediatric HIV by 2030. “Children living with HIV... Read More